Dapagliflozin exhibits class I antiarrhythmic effects which suppress action potential formation in human atrial cardiomyocytes von Paasche, A, Wiedmann, F, Javorszky, N, Yesilgoez, B, Blochberger, P, Kraft, M, Frey, N, Schmidt, C

Volltext

Evaluating the reversibility potential of atrial cardiomyopathy on a clinical and cellular level von Wiedmann, F, Paasche, A, Yesilgoez, B, Kraft, M, Blochberger, P L, Frey, N, Schmidt, C

Volltext

Atrial tattoos lines: a new method to terminate atrial fibrillation von Schmidt, C, Wiedmann, F, Blochberger, P, Paasche, A, Yesilgoez, B, Kraft, M, Loewe, A, Loewe, A, Kallenberger, S, Frey, N

Volltext

Comparison of the antiarrhythmic potential of doxapram and its metabolite ketodoxaparam von Kraft, M, Wiedmann, F, Foerster, K I, Sauter, M, Paasche, A, Blochberger, P L, Yesilgoez, B, L'hoste, Y, Arif, R, Warnecke, G, Karck, M, Frey, N, Burhenne, J, Haefeli, W E, Schmidt, C

Volltext